ATOMIC SARMS
$104
- Appetite Suppression
- Lowers Blood Sugar
- Systemic Fat Loss
Tirzepatide is a dual GIP and GLP-1 receptor agonist. It provides powerful appetite suppression, significantly lowers blood sugar levels, and accelerates systemic fat loss.
Tirzepatide is a synthetic linear peptide of 39 amino acids featuring a C20 fatty-diacid moiety that extends its half-life. It is a first-in-class dual agonist of the GIP and GLP-1 receptors and is supplied here as a lyophilized powder for research use.
Tirzepatide activates both the GIP and GLP-1 receptors. It is characterized in the literature as an “imbalanced” dual agonist — with affinity for GIPR comparable to native GIP but roughly 5-fold weaker affinity for GLP-1R than native GLP-1 — targeting multiple metabolic pathways at once.
Its half-life is approximately 5 days, which in clinical studies is consistent with once-weekly subcutaneous administration.
Store the lyophilized powder at -20°C, away from light. Reconstitute with bacteriostatic water added slowly down the vial wall, swirl gently (never shake), and refrigerate the reconstituted solution at 2–8°C.
No. All products are supplied strictly for laboratory and research use only. They are not approved for human or veterinary use, diagnosis, treatment, or consumption.